Leap Therapeutics Inc (LPTX)

$2.11

-0.14

(-6.22%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $2.09
    $2.20
    $2.11
    downward going graph

    0.9%

    Downside

    Day's Volatility :4.95%

    Upside

    4.09%

    downward going graph
  • $1.24
    $5.00
    $2.11
    downward going graph

    41.23%

    Downside

    52 Weeks Volatility :75.2%

    Upside

    57.8%

    downward going graph

Returns

PeriodLeap Therapeutics IncIndex (Russel 2000)
3 Months
-31.61%
0.0%
6 Months
-15.41%
0.0%
1 Year
-23.73%
0.0%
3 Years
-83.7%
-19.9%

Highlights

Market Capitalization
81.3M
Book Value
$1.85
Earnings Per Share (EPS)
-1.25
PEG Ratio
0.75
Wall Street Target Price
11.38
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-44.12%
Return On Equity TTM
-74.43%
Revenue TTM
375.0K
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
1.5M
EBITDA
-58.0M
Diluted Eps TTM
-1.25
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.71
EPS Estimate Next Year
-1.54
EPS Estimate Current Quarter
-0.58
EPS Estimate Next Quarter
-0.62

Analyst Recommendation

Buy
    90%Buy
    10%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Leap Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
10
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 439.34%

Current $2.11
Target $11.38

Technicals Summary

Sell

Neutral

Buy

Leap Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Leap Therapeutics Inc
Leap Therapeutics Inc
19.68%
-15.41%
-23.73%
-83.7%
-88.34%
Moderna, Inc.
Moderna, Inc.
-11.5%
19.92%
-1.43%
-63.9%
737.94%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.78%
11.32%
45.17%
82.69%
236.57%
Novo Nordisk A/s
Novo Nordisk A/s
-6.33%
26.68%
64.47%
198.6%
438.18%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.24%
14.68%
37.33%
146.48%
182.87%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Leap Therapeutics Inc
Leap Therapeutics Inc
NA
NA
0.75
-1.71
-0.74
-0.44
NA
1.85
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.55
31.55
1.46
44.35
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.95
45.95
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.16
32.16
0.53
17.04
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Leap Therapeutics Inc
Leap Therapeutics Inc
Buy
$81.3M
-88.34%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.9B
737.94%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.9B
236.57%
31.55
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$591.6B
438.18%
45.95
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.0B
182.87%
32.16
39.46%

Insights on Leap Therapeutics Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 64.5% return, outperforming this stock by 88.2%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 193.7% return, outperforming this stock by 277.4%

Institutional Holdings

  • Baker Bros Advisors LP

    3.06%
  • Rock Springs Capital Management LP

    2.38%
  • Vanguard Group Inc

    2.27%
  • Balyasny Asset Management LLC

    1.75%
  • Samsara BioCapital, LLC

    1.75%
  • Adage Capital Partners Gp LLC

    1.25%

Company Information

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.

Organization
Leap Therapeutics Inc
Employees
54
CEO
Mr. Douglas E. Onsi J.D.
Industry
Health Technology

FAQs